Wednesday, September 16, 2009

GSK - Paxil: “If neg, results can bury,”

An executive of GlaxoSmithKline Plc, the world’s second-biggest drugmaker, talked about burying negative studies linking its antidepressant drug Paxil to birth defects, according to a company memo introduced at a trial.

“If neg, results can bury,” Glaxo executive Bonnie Rossello wrote in a 1997 memo on what the company would do if forced to conduct animal studies on the drug. The memo was read during opening statements in the trial of a lawsuit brought by the family of a child born with heart defects.

3 comments:

Anonymous said...

This quote clearly indicates to me that negative results could bury the compound. From what is presented here, it seems that someone has intrepreted this comment to further a lawsuit purely to gain profit.

Anonymous said...

Bollocks!

Anonymous said...

http://www.bigpharmavictim.blogspot.com/